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Abstract
Purpose Palliative care referral is primarily based on clinician
judgment, contributing to highly variable access.
Standardized criteria to trigger automatic referral have been
proposed, but it remains unclear how best to apply them in
practice. We conducted a Delphi study of international experts
to identify a consensus for the use of standardized criteria to
trigger automatic referral.
Methods Sixty international experts stated their level of agree-
ment for 14 statements regarding the use of clinician-based
referral and automatic referral over two Delphi rounds. A con-
sensus was defined as an agreement of ≥70% a priori.
Results The response rate was 59/60 (98%) for the first round
and 56/60 (93%) for the second round. Twenty-six (43%), 19
(32%), and 11 (18%) respondents were from North America,
Asia/Australia, and Europe, respectively. The panel reached
consensus that outpatient palliative care referral should be
based on both automatic referral and clinician-based referral
(agreement = 86%). Only 18% felt that referral should be
clinician-based alone, and only 7% agreed that referral should
be based on automatic referral only. There was consensus that
automatic referral criteria may increase the number of referrals
(agreement = 98%), facilitate earlier palliative care access, and
help administrators to set benchmarks for quality improve-
ment (agreement = 86%).
Conclusions Our panelists favored the combination of auto-
matic referral to augment clinician-based referral. This inte-
grated referral framework may inform policy and program
development.
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Introduction
Timely involvement of specialty palliative care concurrent
with primary palliative care provided by oncology teams has
been shown to enhance patient-related outcomes, including
symptom control, quality of life, quality of end-of-life care,
patient and caregiver satisfaction, and possibly survival [2, 17,
18]. The growing body of literature has led to endorsement of
timely specialty palliative care referral by multiple profession-
al oncology organizations [3, 13, 16].
While there is consensus that a palliative care referral can
benefit cancer patients, many questions remain. When is the
optimal time for referral?Who is the ideal subject? And how to
standardize the referral process? To address the first two ques-
tions, a recent international study by our team identified 11
major consensus criteria and 36 minor criteria for outpatient
palliative care referral [10]. However, how these criteria can
be put into practice remains to be addressed.
Conceptually, palliative care referral may be initiated by
either the oncology team based on clinical judgment or auto-
matic triggers based on pre-defined referral criteria. Currently,
referral is predominantly driven by clinicians. Although auto-
matic referral has some theoretical advantages [7], few studies
have examined how automatic referral can be applied in prac-
tice [1, 5, 14]. A better understanding of this aspect may help
to improve patients’ access to palliative care. We conducted a
Delphi study of international experts to identify a consensus
for the use of standardized criteria to trigger automatic referral.
Methods
Participants
This study is part of a Delphi survey to examine time-
based and need-based referral criteria for outpatient pal-
liative care for patients with advanced cancer, which has
been reported recently [10]. The current study focuses
on the application of these standardized criteria to trig-
ger an automatic referral. As described previously, we
identified international experts based on a literature re-
view on outpatient palliative care, membership involve-
ment in various professional organizations (i.e., the
NCCN Palliative Care Guideline Committee, the
ESMO Pa l l i a t i v e Ca r e Wo rk i n g G roup , t h e
Multinational Association of Supportive Care in Cancer
(MASCC) Palliat ive Care study group, and the
European Association for Palliative Care), and nomina-
tions by the steering committee. These individuals were
invited to participate in the Delphi study if they meet
the following inclusion criteria: (1) a physician with an
active (at least 20% clinical) specialty clinical practice
in either palliative care and/or oncology, with at least
5 years of post-qualification clinical experience; (2)
working at a center with outpatient palliative care ac-
cess; (3) at least one of the following: board certifica-
tion or equivalent in both oncology and palliative care,
have published in the area of integration of palliative
care and oncology in the last 10 years, have been in-
volved in national/international palliative care guideline
development on the topic of integration; and (4) able to
communicate in written English. These criteria were de-
signed to be highly stringent to include only clinicians
who have a strong understanding of outpatient palliative
cancer care. This study was approved by the institution-
al review board at MD Anderson Cancer Center with
wavier of informed consent.
Survey process
Web-based surveys were sent to participants using the
Qualtrics Survey Software (Qualtrics, Utah, USA) between
September 28, 2015 and January 4, 2016. The Delphi study
consisted of two rounds separated 6 weeks apart. The duration
of each round was 4 weeks. We sent weekly e-mail reminders
to non-responders.
We provided the panelists with the following descriptions
of clinician-based referral and automatic referral: “Automatic
referral involves the use of pre-defined criteria (e.g. diagnosis,
prognosis, performance status, symptom intensity, etc) to trig-
ger an outpatient palliative care consultation. This is in con-
trast to clinician-based referral, which relies on the oncology
team to initiate a palliative care referral based on clinician’s
intuition and/or pre-defined referral criteria. Importantly, au-
tomatic referral and clinician-based referral are not mutually
exclusive.”
We then presented the panelists with 14 statements: nine
related to perceived advantages and disadvantages of automat-
ic referral criteria and five on how they may be used in prac-
tice. These questions were generated based on literature re-
view and discussions among steering committee members [1,
5, 14]. The full list of questions is shown in Table 1. Their
answers were coded on a 5-point Likert scale (“strongly
agree,” “agree,” neither agree nor disagree,” “disagree,” and
“strongly disagree”). They were also given a text box to pro-
vide any comments related to automatic referral. A consensus
in this study was defined a priori as an agreement (i.e.,
“Strongly agree” and “agree”) by a minimum of 70% of the
experts, consistent with standards in other Delphi studies [6].
We also collected various demographic information from the
experts.
The second Delphi round asked the panelists to rate their
agreement on the same 14 statements independently and also
provide them with the percentage of agreement for each state-
ment from the first round. Because of the stability of findings,
we stopped this portion of this study after the second round.
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Statistical analysis
We used descriptive statistics to summarize the data.
Statistical analysis was conducted with STATA version 12.1
(College Station, TX, USA).
Results
Response rates and panelist characteristics
The response rate was 59/60 (98%) in the first round and 56/
60 (93%) among the 60 experts participating in this study.
Thirty-eight (63%) were male, and 32 (54%) were dually
trained in both oncology and palliative care. Twenty-six
(43%), 19 (32%), and 11 (18%) respondents were from
North America, Asia/Australia, and Europe, respectively.
The panelists had a median of 10 years in palliative care
(interquartile range [IQR] 7–18.5 years) and 12 years in on-
cology (IQR 8–20 years).
Perceived advantages and disadvantages associated
with automatic referral
The first and second Delphi rounds showed very similar find-
ings, with the same four of the 14 statements reaching con-
sensus (Table 1). A majority of the panelists believed that
automatic referral is associated with both greater number (sec-
ond round agreement = 98%) and earlier referrals (agree-
ment = 98%). They can also be useful as benchmarks for
quality improvement (agreement = 86%).
Several statements did not reach the threshold for
consensus. Thirty-two (58%) believed that automatic re-
ferral may result in greater collaboration between oncol-
ogists and palliative care specialists; however, 24 (43%)
felt it may result in conflicts between the two teams,
Table 1 Statements regarding
automatic referral Statements Level of agreement N
(%)a
First
round
Second
round
Automatic referral criteria may increase the number of outpatient palliative care
referrals.
56 (95) 55 (98)
Automatic referral criteria may facilitate earlier palliative care access for cancer
patients.
55 (93) 55 (98)
Automatic referral criteria may help administrators to set benchmarks for quality
improvement.
46 (79) 48 (86)
Automatic referral criteria may result in greater collaboration between oncologists and
palliative care specialists.
35 (60) 32 (58)
Automatic referral criteria may decrease the autonomy of clinicians to deliver primary
supportive/palliative care.
32 (56) 29 (52)
Automatic referral criteria may hinder clinicians’ ability to refer patients to palliative
care.
16 (28) 5 (9)
Automatic referral criteria may decrease the number of outpatient palliative care
referrals.
5 (9) 1 (2)
Automatic referral criteria may result in conflicts between oncologists and palliative
care specialists.
30 (52) 24 (43)
Automatic referral mandates routine screening in the oncology clinic which is too
burdensome to conduct regularly.
21 (36) 13 (23)
Automatic referral criteria need to be institution specific. 34 (59) 31 (55)
Automatic referral criteria need to be tumor type specific. 30 (52) 25 (45)
Outpatient palliative care referral should be based on both automatic referral and
clinician-based referral.
50 (86) 48 (86)
Outpatient palliative care referral should be based on automatic referral instead of
clinician-based referral.
16 (28) 4 (7)
Outpatient palliative care referral should be based on clinician-based referral instead of
automatic referral.
10 (17) 10 (18)
Items that reached consensus threshold are highlighted in italics
a A consensus in this study was defined a priori as an agreement (i.e., BStrongly agree^ and Bagree^) by a
minimum of 70% of the experts. The numbers were italicized if they reached this threshold
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and 29 (52%) perceived it may hinder clinicians’ ability
to refer patients to palliative care. Only a small propor-
tion of panelists felt that automatic referral is associated
with other negative consequences, such as hindering
clinician-based referral (n = 5, 9%), decreasing the
number of referrals (n = 1, 2%), or resulting in extra
burden for clinicians to conduct (n = 13, 23%).
Several individuals commented on the subtleties of auto-
matic referral:
Difficult balance here, I think there are definitely pa-
tients who are missing out on referral due to a range of
patient and clinician factors that are well described that
may benefit from ‘automatic’ referral, however a pro-
portion will probably not need referral anyway, and will
exacerbate resource constraints which are definitely an
issue.
I think triggers may help a clinic get started but, once
established, are not necessary. I favor more collaborative
and facilitative way of starting the clinic and establish-
ing a practice such as placing the PC provider immedi-
ately next to an oncologist in the workroom space and
letting the partnership grow naturally. I am, in general,
opposed to automatic triggers because they tend to cre-
ate animosity, open us up to critique based on cost (these
consults aren’t free), are very atypical in the health sys-
tem so unfamiliar, often result in patients who are not
particularly appropriate, and require a great deal of time
explaining why they were “forced” to come and see
someone. The set up, even with the patient, can be op-
positional - where else in the healthcare system are they
required to go and have a consult?
Application of automatic referral in practice
The panelists reached consensus that outpatient pallia-
tive care referral should be based on both automatic
referral and clinician-based referral (n = 48, agree-
ment = 86%). Only four (7%) and 10 (18%) of panelists
preferred automatic referral alone or clinician-based re-
ferral alone (Table 1).
Our panelists also shared further insights:
Although automatic triggers might be very helpful, they
should be adopted through consensus planning among
all clinicians involved (especially MDs in both special-
ties but also other health professionals as well) and their
success/value should be reviewed on a regular
(quarterly) basis. Thus, even ‘automatic triggers’ should
‘feel’ like they are part of the regular clinician-based
referral process, otherwise they could be a major source
of conflict.
I think that automatic triggers could help physicians
highlighting “frail” situations and leading up to a more
specific clinician-based evaluation.
Discussion
Our Delphi panel reached a consensus that automatic referral
may improve the volume and timing of palliative care referral.
The panelists favored the combination of automatic referral to
augment clinician-based referral, instead of either referral
model alone. Based on these insights, we proposed a concep-
tual framework of how automatic referral can be used to aug-
ment clinician-based referral.
Currently, clinician-based referral is the predominant path
to palliative care access in most centers. The process can be
broken down into three steps: (1) recognition of care needs;
(2) judging whether this warrants a referral; and (3) initiating a
palliative care consultation. Typically, all three steps are con-
ducted by the oncology team, contributing to wide variations
in referral because of differences in judgment, time, education,
experience, interest, and understanding of palliative care [11,
15]. Although some patients may be referred close to the time
of diagnosis, many patients were either not referred or referred
within the last days of life, which can significantly diminish
the effectiveness of palliative care [9].
To overcome this inequity in palliative care access, auto-
matic referral has been proposed. Under this model, patients
care needs are routinely screened, and patients are automati-
cally referred to palliative care if they met the pre-defined
criteria. This system-based approach may run parallel and be
completely independent to the operations of the oncology
team, minimizing human error and judgment. Automatic re-
ferral has not been very well tested in clinical practice. A
recent survey of 22 NCCN institutions revealed that 3/22
(14%) inpatient programs and 4/22 (18%) outpatient programs
had automatic referral in place, although the details of the
referral process were unavailable [4]. Rocque et al. examined
the implementation of triggered universal palliative care con-
sultation for all hospitalized patients with a diagnosis of ad-
vanced cancer. The referral rate increased from 12 to 60%
[14]. The vetoing power of the oncology team, inadequate
palliative care staffing, and short duration of admission were
cited as reasons that not all patients who met the criteria were
referred. In a before–after comparison, Adelson et al. exam-
ined the application of automatic referral for inpatients and
noted a significant increase in the frequency of palliative care
referral (82 versus 41%;P < 0.0001), a reduction in the 30-day
readmission rate (17 versus 36%; P = 0.02), and an increase in
hospice referral, albeit non-statistically significant (25 versus
14%;P = 0.15) [1].Most recently, our team reported the use of
the Edmonton Symptom Assessment Scale for routine
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symptom distress screening in a general oncology outpatient
clinic [8, 12]. Patients who reported three or more symptoms
with intensity ≥7/10 were assessed by a social worker for
triaging. Before and after program implementation, the propor-
tion of highly distressed patients who were referred to palliative
care increased from 12 (4 of 34) to 28% (15 of 58), albeit not
statistically significant. More studies are clearly needed to ex-
amine the outcomes associated with automatic referral.
Ultimately, few experts felt that clinician-based referral
alone nor automatic referral alone would be ideal. Instead,
they reached consensus on a combination of both approaches.
Exactly how the two approaches should be combined remains
to be investigated. Theoretically, referral can be classified as
“parallel referral” and “augmented referral”. Under the paral-
lel referral model, automatic referral could run independently
to clinician-based referral, with the computer generating a
palliative care referral for any eligible patients not already
referred by the clinical team. Importantly, the standardized
criteria used should be agreed upon by all stakeholders (e.g.,
the oncology team, the palliative care team, and administra-
tion). In essence, randomized controlled trials of concurrent
palliative care versus routine oncologic care offer insights into
how parallel referral compares to clinician-based referral only,
demonstrating that parallel referral is associated with greater
and earlier palliative care access and improved health out-
comes [17, 18]. Alternatively, under the augmented referral
model, automatic referral may augment clinician-based refer-
ral by alerting the clinician of screening findings, electronical-
ly prompting the clinician to refer patients who meet the pre-
defined criteria, and/or asking them for permission to initiate
the referral. This method emphasizes a collaborative approach
to patient care with system features to enhance practice and
may overcome the challenges associated with either referral
approaches alone. Because clinicians act as gatekeepers, fewer
individuals will likely be referred compared to the parallel
referral model [14]. Further research is needed to examine
the feasibility and outcomes associated with these twomodels.
Although randomized trials support that patients with ad-
vanced cancer can benefit from a palliative care referral
starting around the time of diagnosis, implementation of uni-
versal referral is not feasible given the scarce institutional
resources. Thus, more selective criteria are needed and would
likely need to be customized to each institution based on the
existing level of primary and secondary palliative care. An
international panel recently identified 11 major criteria on
when patients should be referred, which may inform how we
can standardize the referral process [10].
This study has several limitations. By design, we included
only highly selective experts in this Delphi studywho are active
clinically and have an in-depth understanding of outpatient pal-
liative cancer care, although their opinions may not reflect that
of the greater oncology, primary care, and palliative care com-
munities. Future studies are needed to understand how clinical
teams perceive automatic referral in everyday practice. Further
research is also required to examine the preferences of patients
and family caregivers in regard to how a palliative care referral
should be triggered. Developing nations were under-
represented among our panelists, and the process of referral
may be different in these countries. This study also focused
on outpatient palliative care referral instead of inpatient referral.
In summary, international oncology and palliative care ex-
perts identified a consensus for combining automatic referral
with clinician-based referral to streamline symptom screening,
referral decisions, and referral initiation. We propose parallel
referral and augmented referral as two conceptual models op-
erating in between the two extremes of purely clinician-based
referral and purely system-based referral. If successfully im-
plemented, these referral models may result in greater number
of timely palliative care referral for cancer patients. Further
studies are needed to examine the feasibility of their imple-
mentation and the impact on referral pattern and patient
outcomes.
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